BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29619629)

  • 21. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
    Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
    J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.
    Ishii K; Ogaya T; Song Z; Iizuka H; Fukushima T
    Chirality; 2010 Nov; 22(10):901-6. PubMed ID: 20872665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drosophila mutants of the kynurenine pathway as a model for ageing studies.
    Savvateeva-Popova EV; Popov AV; Heinemann T; Riederer P
    Adv Exp Med Biol; 2003; 527():713-22. PubMed ID: 15206794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
    Kucukkarapinar M; Yay-Pence A; Yildiz Y; Buyukkoruk M; Yaz-Aydin G; Deveci-Bulut TS; Gulbahar O; Senol E; Candansayar S
    J Neural Transm (Vienna); 2022 Aug; 129(8):1077-1089. PubMed ID: 35796878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the type of exercise affect tryptophan catabolism in horses?
    Kędzierski W; Sadok I; Kowalik S; Janczarek I; Staniszewska M
    Animal; 2021 Nov; 15(11):100377. PubMed ID: 34624767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
    Breda C; Sathyasaikumar KV; Sograte Idrissi S; Notarangelo FM; Estranero JG; Moore GG; Green EW; Kyriacou CP; Schwarcz R; Giorgini F
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5435-40. PubMed ID: 27114543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LC-MS/MS-based quantification of tryptophan, kynurenine, and kynurenic acid in human placental, fetal membranes, and umbilical cord samples.
    Pedraz-Petrozzi B; Marszalek-Grabska M; Kozub A; Szalaj K; Trzpil A; Stachniuk A; Lamadé EK; Gilles M; Deuschle M; Turski WA; Fornal E
    Sci Rep; 2023 Aug; 13(1):12554. PubMed ID: 37532780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia.
    Antenucci N; D'Errico G; Fazio F; Nicoletti F; Bruno V; Battaglia G
    Schizophrenia (Heidelb); 2024 Feb; 10(1):27. PubMed ID: 38413629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes.
    Oxenkrug GF
    Mol Neurobiol; 2015 Oct; 52(2):805-10. PubMed ID: 26055228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
    Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
    Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine.
    Oxenkrug GF
    J Neural Transm (Vienna); 2010 Jan; 117(1):23-6. PubMed ID: 19941150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
    Notarangelo FM; Beggiato S; Schwarcz R
    Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Tryptophan-Derived AhR Ligands, Kynurenine, Kynurenic Acid and FICZ, on Proliferation, Cell Cycle Regulation and Cell Death of Melanoma Cells-In Vitro Studies.
    Walczak K; Langner E; Makuch-Kocka A; Szelest M; Szalast K; Marciniak S; Plech T
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease.
    Dudzińska E; Szymona K; Kloc R; Gil-Kulik P; Kocki T; Świstowska M; Bogucki J; Kocki J; Urbanska EM
    Therap Adv Gastroenterol; 2019; 12():1756284819881304. PubMed ID: 31666808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients.
    Marković M; Petronijević N; Stašević M; Stašević Karličić I; Velimirović M; Stojković T; Ristić S; Stojković M; Milić N; Nikolić T
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.